Jacqueline E. Shea - 10 May 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Executive Officer, Director
Signature: /s/ Jacqueline E. Shea
Issuer symbol: INO
Transactions as of: 10 May 2023
Net transactions value: -$23,250
Form type: 4
Filing time: 12 May 2023, 16:12:32 UTC
Previous filing: 13 Mar 2023
Next filing: 17 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+66,000	+41%		226,817	10 May 2023	Direct	F1
transaction	INO	Common Stock	Tax liability	$23,250	-28,704	-13%	$0.8100	198,113	10 May 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-66,000	-33%	$0.000000	132,000	10 May 2023	Common Stock	66,000		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.